Jefferies Lifts Target on Edwards Lifesciences (EW) on Positive Panel
Tweet Send to a Friend
Jefferies boosted its price target on Buy-rated Edwards Lifesciences (NYSE: EW) from $92 to $100 following a positive FDA panel ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
